<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7493775\results\search\testTrace\results.xml">
  <result pre="of SARS-like illness all over the world. As the SARS-CoV-2" exact="infection" post="pandemic proceeds, many efforts are being dedicated to the"/>
  <result pre="many efforts are being dedicated to the development of diverse" exact="treatment" post="strategies. Increasing evidence showed potential therapeutic agents directly acting"/>
  <result pre="and is responsible for inducing host immune response.3 The CoV" exact="infection" post="begins with the interaction of the receptor binding domain"/>
  <result pre="host receptor, ACE2 for its attachment and entry. Therefore, the" exact="treatment" post="strategy designed for SARS-CoV can be potentially applied to"/>
  <result pre="for treating coronavirus infections. To enhance the progress of potential" exact="treatment" post="for coronaviruses especially for SARS-CoV and MERS-CoV, repurposing of"/>
  <result pre="inhibiting RdRp (like remdesivir) that has been approved for the" exact="treatment" post="of influenza.22 The clinical evaluation for its efficacy and"/>
  <result pre="metabolism of the latter. It has been used for the" exact="treatment" post="of COVID-19 patients.26â€&quot;28 However, lopinavirâ€&quot;ritonavir treatment might not have"/>
  <result pre="been used for the treatment of COVID-19 patients.26â€&quot;28 However, lopinavirâ€&quot;ritonavir" exact="treatment" post="might not have benefit in the severe COVID-19 hospitalized"/>
  <result pre="innate immunity. Hence, targeting specific coronaviral proteases is a potential" exact="treatment" post="option against coronaviruses.31 Cinanserin, an old serotonin receptor antagonist,"/>
  <result pre="pandemic. Using the worldâ€™s most powerful supercomputer, SUMMIT, the high-throughput" exact="screening" post="of the possible docking models and identification of novel"/>
  <result pre="(TMPRSS2).37 Hence, camostat mesylate, a TMPRSS2 inhibitor, can eliminate SARS-CoV-2" exact="infection" post="in vitro assay. On the other hand, the heptad"/>
  <result pre="commonly discussed, this aspect whatever used for adjuvant or single" exact="treatment" post="might be worthy to reassess in the future development"/>
  <result pre="or antisense oligonucleotides against the virus might be another potential" exact="treatment" post="strategy.63 However, several challenges still exist, first, the conserved"/>
  <result pre="a New Jersey-based therapeutics company declared that, â€œCYNK-001, a cancer" exact="treatment" post="is under clinical trial against COVID-19 awaiting for FDA"/>
  <result pre="a characteristic developed by some COVID-19 patients. Therefore, the clinical" exact="testing" post="should proceed with extreme caution and carefully monitor the"/>
  <result pre="in a signal-dependent SARS-CoV nucleocapsid protein nucleocytoplasmic trafficking during SARS-CoV" exact="infection" post="and could affect host cell division.76â€&quot;80 Besides, the SARS-CoV"/>
  <result pre="activity. Recently, an in vitro experiment showed that a single" exact="treatment" post="with ivermectin resulted in about 5000-fold reduction in SARS-CoV-2"/>
  <result pre="AmerongenGet al.Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus" exact="infection" post="in macaques.Nat Med2004;10:290â€&quot;3.14981511 12.BijlengaGProposal for vaccination against SARS coronavirus"/>
  <result pre="corticosteroids in severe acute respiratory syndrome: a preliminary study.JAMA2003;290:3222â€&quot;8.14693875 14.MustafaSBalkhyHGabereMNCurrent" exact="treatment" post="options and the role of peptides as potential therapeutic"/>
  <result pre="amidst uncertainty.N Engl J Med2003;348:1947â€&quot;8.12748313 16.TanELOoiEELinCYTanHCLingAELimBet al.Inhibition of SARS coronavirus" exact="infection" post="in vitro with clinically approved antiviral drugs.Emerg Infect Dis2004;10:581â€&quot;6.15200845"/>
  <result pre="patients with SARS in the greater Toronto area.JAMA2003;289:2801â€&quot;9.12734147 18.CyranoskiDCritics slam" exact="treatment" post="for SARS as ineffective and perhaps dangerous.Nature2003;423:4.12721587 19.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet al.collab:"/>
  <result pre="24.ChanJFYaoYYeungMLDengWBaoLJiaLet al.Treatment with lopinavir/ritonavir or interferon-Î²1b improves outcome of MERS-CoV" exact="infection" post="in a Nonhuman Primate Model of Common Marmoset.J Infect"/>
  <result pre="disease 2019 in Korea: the application of lopinavir/ritonavir for the" exact="treatment" post="of COVID-19 pneumonia monitored by quantitative RT-PCR.J Korean Med"/>
  <result pre="by decreasing autophagosome-lysosome fusion.Autophagy2018;14:1435â€&quot;55.29940786 36.GautretPLagierJCParolaPHoangVTMeddebLMailheMet al.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trial.Int"/>
  <result pre="and are potential drug targets.J Virol2015;89:4387â€&quot;404.25653444 42.RichardsonPGriffinITuckerCSmithDOechsleOPhelanAet al.Baricitinib as potential" exact="treatment" post="for 2019-nCoV acute respiratory disease.Lancet2020;395:e30â€&quot;1.32032529 43.HuangCWangYLiXRenLZhaoJHuYet al.Clinical features of"/>
  <result pre="Review of Early and Emerging Options.Open Forum Infect Dis2020;7:ofaa105.32284951 45.BrisonEJacomyHDesforgesMTalbotPJNovel" exact="treatment" post="with neuroprotective and antiviral properties against a neuroinvasive human"/>
  <result pre="The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the" exact="treatment" post="of severe acute respiratory infections of viral etiology: a"/>
  <result pre="rationale for gene delivery systems.Kona2016;33:63â€&quot;85.27081214 65.NguyenTMZhangYPandolfiPPVirus against virus: a potential" exact="treatment" post="for 2019-nCov (SARS-CoV-2) and other RNA viruses.Cell Res2020;30:189â€&quot;90.32071427 66.Ben"/>
  <result pre="HIV-1 and dengue virus.Biochem J2012;443:851â€&quot;6.22417684 73.WagstaffKMRawlinsonSMHearpsACJansDAAn AlphaScreenÂ®-based assay for high-throughput" exact="screening" post="for specific inhibitors of nuclear import.J Biomol Screen2011;16:192â€&quot;200.21297106 74.CalyLWagstaffKMJansDANuclear"/>
  <result pre="respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during" exact="infection" post="and after expression as a recombinant protein in vero"/>
 </snippets>
</snippetsTree>
